Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q2 2026 ▲▼ | Q3 2026 ▲▼ | Change ▲▼ | Q2 2026 ▲▼ | Q3 2026 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Amylyx Pharmaceuticals, Inc.(AMLX) | 4,624,101 | 4,471,356 | -152,745 | $83.05M | $130.12M | 19.05% | +$47.07M |
| ABIVAX Société AnonymeADS(ABVX) | 518,865 | 529,313 | +10,448 | $69.14M | $52.41M | 7.67% | -$16.73M |
| Immix Biopharma Inc | 4,658,429 | 4,661,115 | +2,686 | $48.03M | $48.50M | 7.10% | +$470.5K |
| Pharvaris N V COM | 1,314,122 | 1,393,956 | +79,834 | $45.44M | $44.22M | 6.47% | -$1.23M |
| Vaxcyte, Inc.(PCVX) | 852,914 | 772,258 | -80,656 | $49.58M | $43.94M | 6.43% | -$5.64M |
| Celcuity Inc.(CELC) | 370,318 | 513,847 | +143,529 | $38.74M | $40.86M | 5.98% | +$2.12M |
| Disc Medicine, Inc.(IRON) | 524,730 | 612,661 | +87,931 | $38.38M | $40.10M | 5.87% | +$1.73M |
| Candel Therapeutics Inc | 3,303,686 | 3,476,206 | +172,520 | $34.03M | $36.29M | 5.31% | +$2.26M |
| Jazz Pharmaceuticals plcSHS USD(JAZZ) | 160,938 | 150,340 | -10,598 | $38.78M | $34.81M | 5.10% | -$3.97M |
| Monopar Therapeutics Inc | 311,976 | 312,350 | +374 | $28.89M | $24.88M | 3.64% | -$4.00M |
| Vir Biotechnology, Inc.(VIR) | 770,643 | 2,040,422 | +1,269,779 | $7.85M | $22.81M | 3.34% | +$14.96M |
| Trevi Therapeutics, Inc.(TRVI) | 1,052,043 | 1,573,876 | +521,833 | $19.62M | $22.54M | 3.30% | +$2.92M |
| X4 Pharmaceuticals Inc | 6,973,343 | 7,366,442 | +393,099 | $32.57M | $21.36M | 3.13% | -$11.20M |
| Alumis Inc | 2,915,443 | 2,855,811 | -59,632 | $82.04M | $21.10M | 3.09% | -$60.94M |
| Sagimet Biosciences IncCOM SER A | 1,479,918 | 2,002,813 | +522,895 | $11.44M | $19.79M | 2.90% | +$8.35M |
| Dyne Therapeutics, Inc.(DYN) | 1,057,493 | 837,175 | -220,318 | $23.49M | $13.49M | 1.97% | -$10.00M |
| Alto Neuroscience, Inc.(ANRO) | 182,829 | 518,109 | +335,280 | $4.82M | $13.23M | 1.94% | +$8.40M |
| Ultragenyx Pharmaceutical Inc.(RARE) | 0 | 758,771 | +758,771 | $0 | $11.40M | 1.67% | +$11.40M |
| Zura Bio LtdCL A | 2,101,119 | 2,032,454 | -68,665 | $12.40M | $8.46M | 1.24% | -$3.94M |
| Inhibikase Therapeutics Inc | 3,869,056 | 3,869,056 | 0 | $7.85M | $7.95M | 1.16% | +$96.7K |
| Oculis Holding Ag | 684,880 | 847,444 | +162,564 | $9.50M | $7.92M | 1.16% | -$1.58M |
| Erasca, Inc.(ERAS) | 0 | 514,309 | +514,309 | $0 | $7.54M | 1.10% | +$7.54M |
| Latigo Biotherapeutics Inc | 0 | 300,355 | +300,355 | $0 | $5.02M | 0.73% | +$5.02M |
| Satellos Bioscience Inc | 350,000 | 516,800 | +166,800 | $2.72M | $4.39M | 0.64% | +$1.67M |
| Invivyd, Inc.(IVVD) | 8,392,288 | 0 | -8,392,288 | $7.32M | $0 | — | -$7.32M |
| Ovid Therapeutics Inc.(OVID) | 663,060 | 0 | -663,060 | $1.78M | $0 | — | -$1.78M |